104 related articles for article (PubMed ID: 29845702)
1. Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.
Masaki A; Ishida T; Suzuki S; Ito A; Narita T; Kinoshita S; Ri M; Kusumoto S; Komatsu H; Inagaki H; Ueda R; Iida S
Cancer Sci; 2018 Aug; 109(8):2383-2390. PubMed ID: 29845702
[TBL] [Abstract][Full Text] [Related]
2. RNF8 Dysregulation and Down-regulation During HTLV-1 Infection Promote Genomic Instability in Adult T-Cell Leukemia.
Zhi H; Guo X; Ho YK; Pasupala N; Engstrom HAA; Semmes OJ; Giam CZ
PLoS Pathog; 2020 May; 16(5):e1008618. PubMed ID: 32453758
[TBL] [Abstract][Full Text] [Related]
3. Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.
Watanabe T
Blood; 2017 Mar; 129(9):1071-1081. PubMed ID: 28115366
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of adult T-cell leukemia/lymphoma: A biomarker identification strategy based on preparation and in-solution digestion methods of total proteins.
Sudo H; Tonoyama Y; Ikebe E; Hasegawa H; Iha H; Ishida YI
Leuk Res; 2024 Mar; 138():107454. PubMed ID: 38452534
[TBL] [Abstract][Full Text] [Related]
5. Novel paired CD13-negative (MT-50.1) and CD13-positive (MT-50.4) HTLV-1-infected T-cell lines with differential regulatory T cell-like activity.
Egawa Y; Higuchi T; Hashida Y; Ueno K; Kojima K; Daibata M
Sci Rep; 2024 May; 14(1):12549. PubMed ID: 38822041
[TBL] [Abstract][Full Text] [Related]
6. Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?
Jeang KT
Oncotarget; 2010 Oct; 1(6):453-456. PubMed ID: 21311101
[TBL] [Abstract][Full Text] [Related]
7. In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes.
Saito M; Taylor GP; Saito A; Furukawa Y; Usuku K; Weber JN; Osame M; Bangham CR
J Virol; 2001 Jan; 75(2):1065-71. PubMed ID: 11134322
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers.
Araki K; Harada K; Nakamoto K; Shiroma M; Miyakuni T
Clin Exp Immunol; 2000 Feb; 119(2):259-63. PubMed ID: 10632660
[TBL] [Abstract][Full Text] [Related]
9. HTLV-1 persistence and the oncogenesis of adult T-cell leukemia/lymphoma.
Bangham CRM
Blood; 2023 May; 141(19):2299-2306. PubMed ID: 36800643
[TBL] [Abstract][Full Text] [Related]
10. HTLV-1 infected T cells cause bone loss via small extracellular vesicles.
Pokhrel NK; Panfil A; Habib H; Seeniraj S; Joseph A; Rauch D; Cox L; Sprung R; Gilmore PE; Zhang Q; Townsend RR; Yu L; Yilmaz AS; Aurora R; Park W; Ratner L; Weilbaecher KN; Veis DJ
bioRxiv; 2024 Mar; ():. PubMed ID: 38496506
[TBL] [Abstract][Full Text] [Related]
11. "It's Only a Model": When Protein Structure Predictions Need Experimental Validation, the Case of the HTLV-1 Tax Protein.
Guillon C; Robert X; Gouet P
Pathogens; 2024 Mar; 13(3):. PubMed ID: 38535584
[TBL] [Abstract][Full Text] [Related]
12. HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia-Lymphoma.
Yamagishi M; Fujikawa D; Watanabe T; Uchimaru K
Front Microbiol; 2018; 9():1686. PubMed ID: 30087673
[TBL] [Abstract][Full Text] [Related]
13. CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.
Sakamoto Y; Ishida T; Masaki A; Murase T; Yonekura K; Tashiro Y; Tokunaga M; Utsunomiya A; Ito A; Kusumoto S; Iida S; Ueda R; Inagaki H
Blood; 2018 Aug; 132(7):758-761. PubMed ID: 29930010
[No Abstract] [Full Text] [Related]
14. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Oncogenesis by HTLV-1 Tax.
Mohanty S; Harhaj EW
Pathogens; 2020 Jul; 9(7):. PubMed ID: 32645846
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of HTLV-1 Infection and ATL in Japan: An Update.
Iwanaga M
Front Microbiol; 2020; 11():1124. PubMed ID: 32547527
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and treatment outcomes of opportunistic infections among human T-lymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016.
Kawano N; Nagahiro Y; Yoshida S; Tahara Y; Himeji D; Kuriyama T; Tochigi T; Nakaike T; Shimokawa T; Yamashita K; Ochiai H; Marutsuka K; Mashiba K; Shimoda K; Teshima T; Kikuchi I
J Clin Exp Hematop; 2019; 59(4):156-167. PubMed ID: 31866618
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review.
Nakahata S; Enriquez-Vera D; Jahan MI; Sugata K; Satou Y
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892225
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion.
Mohanty S; Harhaj EW
Pathogens; 2023 May; 12(5):. PubMed ID: 37242405
[TBL] [Abstract][Full Text] [Related]
20. Primary cells from patients with adult T cell leukemia/lymphoma depend on HTLV-1 Tax expression for NF-κB activation and survival.
Hleihel R; Skayneh H; de Thé H; Hermine O; Bazarbachi A
Blood Cancer J; 2023 May; 13(1):67. PubMed ID: 37137914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
